Speaking as a low-level employee in the medtech industry, I can report that a lot of companies are satisfied doing human research in Eastern Europe, where costs are low and regulations lax, but infrastructure is still available. I have heard that there is a bit of “rotation” among these countries over time, since costs and regulations tend to increase wherever human research becomes popular.
Speaking as a low-level employee in the medtech industry, I can report that a lot of companies are satisfied doing human research in Eastern Europe, where costs are low and regulations lax, but infrastructure is still available. I have heard that there is a bit of “rotation” among these countries over time, since costs and regulations tend to increase wherever human research becomes popular.